SEC ownership of BTCS Labs Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002089189.

Comparable stake leader

Charles W. Allen

Disclosed value leader

Exor N.V.

Comparable rows

4/4

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
4 of 4
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Charles W. Allen
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0002089189
Issuer location
Wayne, PA

Ownership snapshot

Top shareholders of BTCS Labs Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Charles W. Allen
Disclosed value leader
Exor N.V.
Comparable rows
4/4
Latest evidence
31 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 80% 13D/G row: Charles W. Allen

Quick read

Charles W. Allen leads the comparable SEC ownership view at 80%.

4 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Charles W. Allen's linked filing trail.
Comparable ownership Top 4
Charles W. Allen 80%
Exor N.V. 617%
ORBIMED ADVISORS LLC 21%
Strategic Investment Solutions, I... 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Charles W. Allen
3/4/5 13D/G
CEO, Pres., Sec. & Treas., Director, 10%+ Owner · BTCS Equity Partners LLC
80%
from 13D/G
$17,185,000
500,000 shares
03 Oct 2025
Exor N.V.
13F
Company
13F
617%
$5,001,704,778
182,543,970 shares
31 Mar 2026
ORBIMED ADVISORS LLC
13F
Company
13F
21%
$22,079,801
6,210,899 shares
31 Mar 2026
Strategic Investment Solutions, Inc. /IL
13F
Company
13F
0%
$29,157
127 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 29 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-1 of 1 reporting-owner rows connected to BTCS Labs Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
1
Largest Forms 3/4/5 holder
Charles W. Allen
Net 12M change
$0
Latest report
03 Oct 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Charles W. Allen CEO, Pres., Sec. & Treas., Director, 10%+ Owner $17,185,000 Mixed 03 Oct 2025

Recent insider transactions for BTCS Labs Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Charles W. Allen Common Stock 0 400,000 03 Oct 2025 By BTCS Equity Partners LLC
Charles W. Allen Common Stock 0 100,000 03 Oct 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .